During the past 100 years, Abbott Nutrition has developed many strong alliances, partnerships, and connections around the world. These scientific collaborations have resulted in countless insights, innovative solutions, and advanced thought. The Abbott Nutrition Health Institute is committed to joining this ongoing community of groups, organizations, and health care professionals in advancing science-based nutrition.
Creating a community of nutrition research partners dedicated to advancing care and bettering lives through science-based nutrition solutions through the exchange of ideas focused on innovative nutrition solutions and education approaches.
The International Food Information Council (IFIC) Foundation is dedicated to the mission of effectively communicating science-based information on health, nutrition and food safety for the public good. The IFIC website
Abbott Nutrition provided grant funding to support a CPE program titled Understanding and Communicating About Biotechnology: A CPE for Registered Dietitian Nutritionists This CPE program covers the current science about food biotechnology as well as common misconceptions about topics such as its safety and uses, impact on health and nutrition, the relationship between food allergies and biotechnology, pesticides, its impact on sustainability, regulation and labeling, and more.
The CNLM supports research aimed at understanding and applying the beneficial effects of nutritional compounds for developing, enhancing, maintaining, and/or restoring critical aspects of learning, memory, and cognition.
The Alliance to Advance Patient Nutrition is an interdisciplinary consortium dedicated to championing effective patient nutrition practices. Launched in 2013, the alliance is comprised of leaders from The Academy of Medical-Surgical Nurses, The Academy of Nutrition and Dietetics, The American Society for Parenteral and Enteral Nutrition, The Society of Hospital Medicine, and Abbott Nutrition.
The Health Technology Park fosters initiatives that promote basic clinical research in the area of health and biomedicine through advanced and prestigious public and private research in the areas of biotechnology and healthcare. This technological space fosters relationships among researchers and industry.
Held in 2012, this 4-day consensus definition conference was co-organized by the FNIH, the National Institutes of Health (NIH), and the US Food and Drug Administration (FDA), and supported by five pharmaceutical companies (Abbott, Amgen, Eli Lilly, Merck, and Novartis), for the purpose of developing a consensus definition of sarcopenia for researchers, clinicians, and regulators.